Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1656

1.

Monitoring of structural changes in the course of acute compressive radial neuropathies by means of high resolution nerve ultrasound.

Motte J, Gold R, Krogias C.

J Neurol Sci. 2018 Aug 15;391:45-47. doi: 10.1016/j.jns.2018.05.021. Epub 2018 May 26. No abstract available.

PMID:
30103969
2.

[Characteristics and dynamics of inpatient treatment of patients with Parkinson's disease in Germany : Analysis of 1.5 million patient cases from 2010 to 2015].

Tönges L, Bartig D, Muhlack S, Jost W, Gold R, Krogias C.

Nervenarzt. 2018 Aug 6. doi: 10.1007/s00115-018-0590-5. [Epub ahead of print] German.

PMID:
30083879
3.

OMG U #Cyberbully! An Exploration of Public Discourse About Cyberbullying on Twitter.

McHugh MC, Saperstein SL, Gold RS.

Health Educ Behav. 2018 Aug 5:1090198118788610. doi: 10.1177/1090198118788610. [Epub ahead of print]

PMID:
30078351
4.

Building Meaningful Patient Engagement in Research: Case Study From ADVANCE Clinical Data Research Network.

Warren NT, Gaudino JA Jr, Likumahuwa-Ackman S, Dickerson K, Robbins L, Norman K, Lind J, D'Amato S, Foley P, Gold R, Bauer V, Fields SA, Cohen DJ, Clark KD, DeVoe JE.

Med Care. 2018 Aug 2. doi: 10.1097/MLR.0000000000000791. [Epub ahead of print]

PMID:
30074953
5.

Flaccid paralysis in neuromyelitis optica: An atypical presentation with possible involvement of the peripheral nervous system.

Grüter T, Ayzenberg I, Gahlen A, Kneiphof J, Gold R, Kleiter I.

Mult Scler Relat Disord. 2018 Jul 20;25:83-86. doi: 10.1016/j.msard.2018.07.032. [Epub ahead of print]

PMID:
30056360
6.

Ovarian Reserve in Women With Neuromyelitis Optica Spectrum Disorder.

Thöne J, Lichtenberg S, Stahl A, Pache F, Kleiter I, Ruprecht K, Gold R, Hellwig K.

Front Neurol. 2018 Jun 19;9:446. doi: 10.3389/fneur.2018.00446. eCollection 2018.

7.

Breakthrough treatment with bortezomib for a patient with anti-NMDAR encephalitis.

Schroeder C, Back C, Koc Ü, Strassburger-Krogias K, Reinacher-Schick A, Gold R, Haghikia A.

Clin Neurol Neurosurg. 2018 Jun 23;172:24-26. doi: 10.1016/j.clineuro.2018.06.005. [Epub ahead of print]

PMID:
29960102
8.

Detection of JC virus archetype in cerebrospinal fluid in a MS patient with dimethylfumarate treatment without lymphopenia or signs of PML.

Motte J, Kneiphof J, Straßburger-Krogias K, Klasing A, Adams O, Haghikia A, Gold R.

J Neurol. 2018 Aug;265(8):1880-1882. doi: 10.1007/s00415-018-8931-7. Epub 2018 Jun 15.

PMID:
29948248
9.

The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis.

Hammer A, Waschbisch A, Kuhbandner K, Bayas A, Lee DH, Duscha A, Haghikia A, Gold R, Linker RA.

Ann Clin Transl Neurol. 2018 Apr 16;5(6):668-676. doi: 10.1002/acn3.553. eCollection 2018 Jun.

10.

DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis.

Kular L, Liu Y, Ruhrmann S, Zheleznyakova G, Marabita F, Gomez-Cabrero D, James T, Ewing E, Lindén M, Górnikiewicz B, Aeinehband S, Stridh P, Link J, Andlauer TFM, Gasperi C, Wiendl H, Zipp F, Gold R, Tackenberg B, Weber F, Hemmer B, Strauch K, Heilmann-Heimbach S, Rawal R, Schminke U, Schmidt CO, Kacprowski T, Franke A, Laudes M, Dilthey AT, Celius EG, Søndergaard HB, Tegnér J, Harbo HF, Oturai AB, Olafsson S, Eggertsson HP, Halldorsson BV, Hjaltason H, Olafsson E, Jonsdottir I, Stefansson K, Olsson T, Piehl F, Ekström TJ, Kockum I, Feinberg AP, Jagodic M.

Nat Commun. 2018 Jun 19;9(1):2397. doi: 10.1038/s41467-018-04732-5.

11.

Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model.

Wilmes AT, Reinehr S, Kühn S, Pedreiturria X, Petrikowski L, Faissner S, Ayzenberg I, Stute G, Gold R, Dick HB, Kleiter I, Joachim SC.

J Neuroinflammation. 2018 Jun 14;15(1):183. doi: 10.1186/s12974-018-1208-3.

12.

Metastatic Gallbladder Melanoma Presenting as Acute Emphysematous Cholecystitis.

Hall N, Grenier NL, Shah SA, Gold R, Feller E.

Case Rep Med. 2018 May 8;2018:5726570. doi: 10.1155/2018/5726570. eCollection 2018.

13.

Evaluation of tolerability and efficacy of incorporating carboplatin in neoadjuvant anthracycline and taxane based therapy in a BRCA1 enriched triple-negative breast cancer cohort.

Sella T, Gal Yam EN, Levanon K, Rotenberg TS, Gadot M, Kuchuk I, Molho RB, Itai A, Modiano TM, Gold R, Kaufman B, Shimon SP.

Breast. 2018 Aug;40:141-146. doi: 10.1016/j.breast.2018.05.007. Epub 2018 May 22.

PMID:
29800932
14.

Correction to: Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010.

Faissner S, Gold R.

CNS Drugs. 2018 May;32(5):469-471. doi: 10.1007/s40263-018-0524-6.

PMID:
29796978
15.

Suppressing tawny crazy ant (Nylanderia fulva) by RNAi technology.

Meng J, Lei J, Davitt A, Holt JR, Huang J, Gold R, Vargo EL, Tarone AM, Zhu-Salzman K.

Insect Sci. 2018 May 22. doi: 10.1111/1744-7917.12604. [Epub ahead of print]

PMID:
29790281
16.

High-Resolution Nerve Ultrasound and Electrophysiological Findings in Restless Legs Syndrome.

Pitarokoili K, Fels M, Kerasnoudis A, Tönges L, Gold R, Yoon MS.

J Neuroimaging. 2018 May 11. doi: 10.1111/jon.12520. [Epub ahead of print]

PMID:
29749662
17.

Electronic health record tools to assist with children's insurance coverage: a mixed methods study.

DeVoe JE, Hoopes M, Nelson CA, Cohen DJ, Sumic A, Hall J, Angier H, Marino M, O'Malley JP, Gold R.

BMC Health Serv Res. 2018 May 10;18(1):354. doi: 10.1186/s12913-018-3159-x.

18.

Advancing Social Prescribing with Implementation Science.

Gottlieb L, Cottrell EK, Park B, Clark KD, Gold R, Fichtenberg C.

J Am Board Fam Med. 2018 May-Jun;31(3):315-321. doi: 10.3122/jabfm.2018.03.170249. No abstract available.

19.

Incidence and mitigation of gastrointestinal events in patients with relapsing-remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TOLERATE).

Gold R, Schlegel E, Elias-Hamp B, Albert C, Schmidt S, Tackenberg B, Xiao J, Schaak T, Salmen HC.

Ther Adv Neurol Disord. 2018 Apr 18;11:1756286418768775. doi: 10.1177/1756286418768775. eCollection 2018.

20.

Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study.

Huhn K, Bayas A, Doerck S, Frank B, Gerbershagen K, Hellwig K, Kallmann B, Kleinschnitz C, Kleiter I, Lee DH, Limmroth V, Mäurer M, Meuth S, Rieckmann P, Ruck T, Gold R, Linker RA.

J Neurol. 2018 Jul;265(7):1521-1527. doi: 10.1007/s00415-018-8871-2. Epub 2018 Apr 25.

PMID:
29696498
21.

Capsaicin-enriched diet ameliorates autoimmune neuritis in rats.

Motte J, Ambrosius B, Grüter T, Bachir H, Sgodzai M, Pedreiturria X, Pitarokoili K, Gold R.

J Neuroinflammation. 2018 Apr 24;15(1):122. doi: 10.1186/s12974-018-1165-x.

22.

Metaphor Comprehension in Low and High Creative Individuals.

Kenett YN, Gold R, Faust M.

Front Psychol. 2018 Apr 9;9:482. doi: 10.3389/fpsyg.2018.00482. eCollection 2018.

23.

Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010.

Faissner S, Gold R.

CNS Drugs. 2018 Mar;32(3):269-287. doi: 10.1007/s40263-018-0488-6. Review. Erratum in: CNS Drugs. 2018 May;32(5):469-471.

PMID:
29600441
24.

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.

Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P, Arnold DL, Arnould S, Scherz T, Wolf C, Wallström E, Dahlke F; EXPAND Clinical Investigators.

Lancet. 2018 Mar 31;391(10127):1263-1273. doi: 10.1016/S0140-6736(18)30475-6. Epub 2018 Mar 23.

PMID:
29576505
25.

High-resolution nerve ultrasound and magnetic resonance neurography as complementary neuroimaging tools for chronic inflammatory demyelinating polyneuropathy.

Pitarokoili K, Kronlage M, Bäumer P, Schwarz D, Gold R, Bendszus M, Yoon MS.

Ther Adv Neurol Disord. 2018 Mar 5;11:1756286418759974. doi: 10.1177/1756286418759974. eCollection 2018.

26.

Mechanical thrombectomy in a young stroke patient with Duchenne muscular dystrophy.

Spicher C, Schneider R, Mönnings P, Schneider-Gold C, Kallenberg D, Cevik B, Lukas C, Gold R, Krogias C.

Ther Adv Neurol Disord. 2018 Mar 1;11:1756286418759188. doi: 10.1177/1756286418759188. eCollection 2018.

27.

Assessing the impact of care farms on quality of life and offending: a pilot study among probation service users in England.

Elsey H, Farragher T, Tubeuf S, Bragg R, Elings M, Brennan C, Gold R, Shickle D, Wickramasekera N, Richardson Z, Cade J, Murray J.

BMJ Open. 2018 Mar 17;8(3):e019296. doi: 10.1136/bmjopen-2017-019296.

28.

Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis.

Graetz C, Gröger A, Luessi F, Salmen A, Zöller D, Schultz J, Siller N, Fleischer V, Bellenberg B, Berthele A, Biberacher V, Havla J, Hecker M, Hohlfeld R, Infante-Duarte C, Kirschke JS, Kümpfel T, Linker R, Paul F, Pfeuffer S, Sämann P, Toenges G, Weber F, Zettl UK, Jahn-Eimermacher A, Antony G, Groppa S, Wiendl H, Hemmer B, Mühlau M, Lukas C, Gold R, Lill CM, Zipp F.

Mult Scler. 2018 Mar 1:1352458518763541. doi: 10.1177/1352458518763541. [Epub ahead of print]

PMID:
29532745
29.

Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36 (2014) 1958-1971].

Kita M, Fox RJ, Gold R, Giovannoni G, Phillips JT, Sarda SP, Kong J, Viglietta V, Sheikh SI, Okwuokenye M, Kappos L.

Clin Ther. 2018 May;40(5):812. doi: 10.1016/j.clinthera.2018.02.005. Epub 2018 Mar 7. No abstract available.

PMID:
29523369
30.

Impact and cost-effectiveness of care farms on health and well-being of offenders on probation: a pilot study.

Elsey H, Bragg R, Elings M, Brennan C, Farragher T, Tubeuf S, Gold R, Shickle D, Wickramasekera N, Richardson Z, Cade J, Murray J.

Southampton (UK): NIHR Journals Library; 2018 Feb.

31.

Treatment choices and neuropsychological symptoms of a large cohort of early MS.

von Bismarck O, Dankowski T, Ambrosius B, Hessler N, Antony G, Ziegler A, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Tackenberg B, Stoppe M, Then Bergh F, Tumani H, Kümpfel T, Stangel M, Heesen C, Wildemann B, Paul F, Bayas A, Warnke C, Weber F, Linker RA, Ziemann U, Zettl UK, Zipp F, Wiendl H, Hemmer B, Gold R, Salmen A.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 1;5(3):e446. doi: 10.1212/NXI.0000000000000446. eCollection 2018 May.

32.

Oral Therapies for Multiple Sclerosis.

Faissner S, Gold R.

Cold Spring Harb Perspect Med. 2018 Mar 2. pii: a032011. doi: 10.1101/cshperspect.a032011. [Epub ahead of print]

PMID:
29500302
33.

Clinical commentary on 'Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis'.

Faissner S, Gold R.

Mult Scler. 2018 Feb 1:1352458518761188. doi: 10.1177/1352458518761188. [Epub ahead of print] No abstract available.

PMID:
29473795
34.

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F.

Mult Scler. 2018 Feb;24(2):96-120. doi: 10.1177/1352458517751049. Epub 2018 Jan 20.

PMID:
29353550
35.

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F.

Eur J Neurol. 2018 Feb;25(2):215-237. doi: 10.1111/ene.13536. Epub 2018 Jan 19. Erratum in: Eur J Neurol. 2018 Mar;25(3):605.

PMID:
29352526
36.

Electronic Health Record Implementation Findings at a Large, Suburban Health and Human Services Department.

Crowley K, Mishra A, Cruz-Cano R, Gold R, Kleinman D, Agarwal R.

J Public Health Manag Pract. 2018 Jan 10. doi: 10.1097/PHH.0000000000000768. [Epub ahead of print]

PMID:
29324567
37.

Role of Nuclear Factor (Erythroid-Derived 2)-Like 2 Signaling for Effects of Fumaric Acid Esters on Dendritic Cells.

Hammer A, Waschbisch A, Knippertz I, Zinser E, Berg J, Jörg S, Kuhbandner K, David C, Pi J, Bayas A, Lee DH, Haghikia A, Gold R, Steinkasserer A, Linker RA.

Front Immunol. 2017 Dec 22;8:1922. doi: 10.3389/fimmu.2017.01922. eCollection 2017.

38.

Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease.

Fatoba O, Kloster E, Reick C, Saft C, Gold R, Epplen JT, Arning L, Ellrichmann G.

Exp Neurol. 2018 Apr;302:112-128. doi: 10.1016/j.expneurol.2018.01.001. Epub 2018 Jan 6.

PMID:
29309751
39.

Dietary fatty acids and susceptibility to multiple sclerosis.

Haase S, Haghikia A, Gold R, Linker RA.

Mult Scler. 2018 Jan;24(1):12-16. doi: 10.1177/1352458517737372.

PMID:
29307296
40.

Grief, poetry, and the sweet unexpected.

Gold R, Jordan E.

Death Stud. 2018 Jan;42(1):16-25. doi: 10.1080/07481187.2017.1370413. Epub 2018 Jan 4.

PMID:
29300144
41.

US reproductive health and rights: beyond the global gag rule.

Gold RB, Starrs AM.

Lancet Public Health. 2017 Mar;2(3):e122-e123. doi: 10.1016/S2468-2667(17)30035-X. Epub 2017 Mar 6. No abstract available.

42.

Delivering Bad News: Attitudes, Feelings, and Practice Characteristics Among Speech-Language Pathologists.

Gold R, Gold A.

Am J Speech Lang Pathol. 2018 Feb 6;27(1):108-122. doi: 10.1044/2017_AJSLP-17-0045.

PMID:
29242920
43.

Multiple sclerosis: Progressive multifocal leukoencephalopathy risk stratification.

Pitarokoili K, Gold R.

Nat Rev Neurol. 2017 Dec;13(12):710-712. doi: 10.1038/nrneurol.2017.161. Epub 2017 Nov 17. No abstract available.

PMID:
29146954
44.

The conserved RNA helicase YTHDC2 regulates the transition from proliferation to differentiation in the germline.

Bailey AS, Batista PJ, Gold RS, Chen YG, de Rooij DG, Chang HY, Fuller MT.

Elife. 2017 Oct 31;6. pii: e26116. doi: 10.7554/eLife.26116.

45.

The Red Yeast Rice story: How to manufacture a tall tale from nature.

Gold KR, Gold R, Avula B, Khan IA.

Eur J Prev Cardiol. 2018 Jan;25(1):73-75. doi: 10.1177/2047487317739080. Epub 2017 Oct 31. No abstract available.

PMID:
29086583
46.

Lewis Rat Model of Experimental Autoimmune Encephalomyelitis.

Pitarokoili K, Ambrosius B, Gold R.

Curr Protoc Neurosci. 2017 Oct 23;81:9.61.1-9.61.20. doi: 10.1002/cpns.36.

PMID:
29058769
47.

Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosis.

Rose JW, Giovannoni G, Wiendl H, Gold R, Havrdová E, Kappos L, Selmaj KW, Zhao J, Riester K, Tsao LC, Greenberg SJ.

Mult Scler Relat Disord. 2017 Oct;17:32-40. doi: 10.1016/j.msard.2017.06.006. Epub 2017 Jun 19.

PMID:
29055471
48.

Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study.

Coyle PK, Khatri B, Edwards KR, Meca-Lallana JE, Cavalier S, Rufi P, Benamor M, Brette S, Robinson M, Gold R; Teri-PRO Trial Group.

Mult Scler Relat Disord. 2017 Oct;17:107-115. doi: 10.1016/j.msard.2017.07.006. Epub 2017 Jul 6.

49.

Publicly Funded Family Planning Under Unprecedented Attack.

Gold RB, Hasstedt K.

Am J Public Health. 2017 Dec;107(12):1895-1897. doi: 10.2105/AJPH.2017.304124. Epub 2017 Oct 19. No abstract available.

50.

How 6 Organizations Developed Tools and Processes for Social Determinants of Health Screening in Primary Care: An Overview.

LaForge K, Gold R, Cottrell E, Bunce AE, Proser M, Hollombe C, Dambrun K, Cohen DJ, Clark KD.

J Ambul Care Manage. 2018 Jan/Mar;41(1):2-14. doi: 10.1097/JAC.0000000000000221.

Supplemental Content

Support Center